Category : InternationalPublished on: March 03 2022
Share on facebook
Canada on Thursday approved the use of Covifenz, the world’s first plant-derived Covid-19 vaccine jointly developed by Medicago Inc. and GlaxoSmithKline Plc.
The vaccine has been cleared for people aged 18 to 64 since its safety and effectiveness.
Covifenz is made from plant-based proteins that look like coronavirus and uses Glaxo’s adjuvant that contains DL-alpha-tocopherol, squalene, polysorbate 80, phosphate-buffered saline.
The other ingredients include potassium phosphate monobasic anhydrous, anhydroussodium chloride, sodium phosphate dibasic anhydrous, and water for injection.
